TITLE

Novel equation effective at predicting survival in pulmonary arterial hypertension

PUB. DATE
February 2010
SOURCE
Cardiology Today;Feb2010, Vol. 13 Issue 2, p16
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses research on the efficacy of a new equation in predicting survival in patients with pulmonary arterial hypertension compared with the equation traditionally used by the National Institutes of Health, with a reference to a study by T. Thenappan that was published in an issue of the 'European Respiratory Journal."
ACCESSION #
47733201

 

Related Articles

  • Pulmonary Hypertension Associated with Congenital Heart Disease: It's Not All the Same. Rosenzweig, Erika Berman // Advances in Pulmonary Hypertension;Winter2013, Vol. 11 Issue 4, p154 

    In this article, the editor mentions that the number of adults suffering with congenital heart diseases has outnumbered the children in past decades from 2013. She further mentions that many of the adults with congenital heart diseases are found to have associated pulmonary arterial hypertension...

  • Dexmedetomidine and Pulmonary Hypertension: A Case Report and Review of the Literature. Raman, Vidya; Tobias, Joseph D. // Journal of Medical Cases;2013, Vol. 4 Issue 7, p481 

    Given its favorable effects on respiratory and hemodynamic function, dexmedetomidine remains a commonly used agent for procedural sedation in various scenarios in infants and children. Procedural sedation may be particularly problematic in patients with co-morbid conditions such as pulmonary...

  • United Therapeutics's oral PAH trial fails primary endpoint.  // PharmaWatch: Biotechnology;Jan2009, Vol. 8 Issue 1, p8 

    The article reports on the results of the Freedom-C trial of oral treprostinil made by United Therapeutics Corp. in pulmonary arterial hypertension in the U.S. It is noted that exploratory analyses suggest that the inability to dose titrate was a limiting issue that muted the overall treatment...

  • Sildenafil And Atorvastatin Added To Bosentan As Therapy For Pulmonary Hypertension. Gomberg-Maitland, Mardi; Gulati, Martha; McLaughlin, Valleria V.; Rich, Stuart // Internet Journal of Pulmonary Medicine;2006, Vol. 6 Issue 1, p1 

    Background: The efficacy and safety of combination therapies for pulmonary hypertension are unknown. Methods: Patients with symptomatic pulmonary hypertension on 125 mg bosentan 2 times daily were randomized by a 2:1 randomization to sildenafil 50 mg 3 times daily and atorvastatin 20 mg daily...

  • We've Come--and Are Going--a Long Way. . . Kingman, Martha; Brady, Daniela // Advances in Pulmonary Hypertension;Fall2012, Vol. 11 Issue 3, p115 

    The article discusses author's views on the issue of long term struggle faced by patients suffering from pulmonary hypertension (PH). It also discusses various treatment modalities for hypertension including Flolan, Tracleer and monotherapy. It mentions that the patient led family session gives...

  • Sildenafil.  // Reactions Weekly;Sep2015, Vol. 1569 Issue 1, p191 

    The article presents case study of a patient who developed ocular side effects during treatment with sildenafil for sarcoidosis-associated pulmonary hypertension.

  • Pulmonary Hypertension in Patients With Interstitial Lung Diseases. Ryu, Jay H.; Krowka, Michael J.; Pellikka, Patricia A.; Swanson, Karen L.; McGoon, Michael D. // Mayo Clinic Proceedings;Mar2007, Vol. 82 Issue 3, p342 

    Pulmonary hypertension (PH) In patients with interstitial lung diseases (ILDs) is not well recognized and can occur in the absence of advanced pulmonary dysfunction or hypoxemia. To address this topic, we identified relevant studies in the English language by searching the MEDLINE database (1966...

  • PDGF signaling in pulmonary arterial hypertension. Barst, Robyn J. // Journal of Clinical Investigation;Oct2005, Vol. 115 Issue 10, p2691 

    The pathobiology of pulmonary arterial hypertension (PAH) includes endothelial cell dysfunction and proliferation and migration of VSMCs. As PDGF has been implicated in these processes, Schermuly et al. hypothesized that altered PDGF signaling may be involved in the vascular remodeling observed...

  • GUEST EDITOR'S MEMO. Studer, Sean M. // Advances in Pulmonary Hypertension;Spring2013, Vol. 12 Issue 1, p2 

    An introduction is presented in which the editor discusses various articles with the issue on topics including preoperative evaluation of pulmonary hypertension patients (PH), surgical preparation for PH patients, and optimization of anesthesia and intraoperative management in PH patients.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics